Cleared Traditional

K231279 - Peregrine System Infusion Catheter 4-7 mm, Peregrine System Infusion Catheter 3-4 mm (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231279 · Ablative Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
63d
Days
Class 2
Risk

K231279 is an FDA 510(k) clearance for the Peregrine System Infusion Catheter 4-7 mm, Peregrine System Infusion Catheter.... Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Ablative Solutions, Inc. (Wakefield, US). The FDA issued a Cleared decision on July 5, 2023 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ablative Solutions, Inc. devices

Submission Details

510(k) Number K231279 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 2023
Decision Date July 05, 2023
Days to Decision 63 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 125d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 172
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K231279.
InVera Infusion Device
K250794 · Invera Medical · Mar 2026
Micro Catheter
K243534 · Suzhou Zenith Vascular SciTech Limited · Jul 2025
XO Cath Microcatheter (E20-090-S, E20-110-S, E20-130-S, E20-150-S, E20-175-S, E20-220-S, E20-090-B, E20-110-B, E20-130-B, E20-150-B, E20-175-B, E20-220-B, E26-090-S, E26-110-S, E26-130-S, E26-150-S, E26-175-S, E26-220-S, E26-090-B, E26-110-B, E26-130-B, E26-150-B, E26-175-B, E26-220-B,)
K231821 · Transit Scientific, LLC · Nov 2023
ScleroSafe™ 150 mm, ScleroSafe™ 350 mm
K231148 · Vvt Medical , Ltd. · Jun 2023
TriSalus TriNav® LV Infusion System
K230957 · Trisalus Life Sciences · May 2023
Wallaby 017 Micro Catheter
K223139 · Wallaby Medical · Apr 2023